IP Library Granted Patent US 7,183,099
Granted Patent B2
US 7,183,099 · App. 10/284,084 · Granted Feb 27, 2007

Inhibitors of autoinducer transporters

Assignee: Princeton University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,183,099
App. No.
10/284,084
Granted
Feb 27, 2007
Kind
B2
Abstract

The present invention relates to the discovery of the lsr operon, the genes therein, and the polypeptides encoded by these genes. The present invention also includes strains with altered expression levels of the polypeptides encoded by the genes and the lsr operon relative to wild type cells. In some embodiments, the strains express a transporter that transports an autoinducer into the cell at a level higher than that of wild type cells. The present invention also includes methods for identifying compounds that modulate the transport of the autoinducer into cells.

Claims (6)

1. An isolated bacterial strain having an increased expression level of a transporter relative to a wildtype strain wherein the transporter transports a pentanedione autoinducer into the strain and wherein the transporter comprises at least one polypeptide having at least 80% amino acid identity using a BLAST search or FASTA version 3.0t78 algorithm with the default parameters, or equivalent search to a peptide selected from the group consisting of SEQ ID NO. 37, SEQ ID NO. 38, SEQ ID NO. 39, and SEQ ID NO. 40, and wherein the autoinducer can interact with the Vibrio harveyi LuxP-LuxQ protein complex, thereby inducing Vibric harveyi bioluminescence.

2. The strain of claim 1 , wherein the strain comprises at least one synthetic vector from which one or more of the transporter polypeptides are expressed.

3. The strain of claim 1 , wherein the transporter comprises polypeptides having at least 80% amino acid identity using a BLASTP, BLASTX, or TBLASTN with the default parameters to SEQ ID NO. 37, SEQ ID NO. 38, SEQ ID NO. 39, and SEQ ID NO. 40.

4. The strain of claim 1 , wherein the strain comprises a mutation in a LsrR repressor gene that increases the expression level of the transporter.

5. The strain of claim 1 , wherein the autoinducer is 4,5-dihydroxy-2,3-pentanedione.

6. The strain of claim 1 , wherein the strain is within a species selected from the group consisting of S. typhimurium and E. coli.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 23, 2016
From: PRINCETON UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 039128/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2003
From: QUOREX PHARMACEUTICALS, INC.
To: PRINCETON UNIVERSITY
Reel/Frame 013787/0492 →
Continuity (2)
Provisional Application 6033632400 · Oct 29, 2001
Related Publication 20030165932A1 · Sep 4, 2003